Angiotech

Angiotech Pharmaceuticals completes acquisition of Quill Medical

Published in Pharma Law Weekly, July 25th, 2006

Angiotech Pharmaceuticals, Inc., (ANPI)()(ANP), a global specialty pharmaceutical and medical device company, announced that it has completed its acquisition of privately held Quill Medical, Inc., - including all of its technology and intellectual property - for US$40 million in cash plus certain future contingent payments based on product revenues, as previously announced on May 25, 2006.

In October 2004, Angiotech's Surgical Specialties division and Quill entered into an exclusive manufacturing and distribution agreement for the Contour Threads product line to be used in minimally-invasive aesthetic and cosmetic surgery. Unlike conventional sutures which are smooth,...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Pharma Law Weekly

Source: Pharma Law Weekly (2006-07-25)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry